TABLE.
Reference, year, location |
Sample size |
ICU type (setup) |
Age (y). mean |
Male sex (%) |
APACHE II score, Mean |
Most cases | Drugs used | Sedation scale (Weaning protocol) |
Intervention | Control | Follow-up | Reported outcomesb |
|||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
I | C | I | C | I | C | ||||||||||
Brook et al,7
1999 Single center United States |
321 | Medical (closed) |
57.8 | 58.1 | 51.2 | 47.2 | 23.1 | 23.2 | Pneumonia | Diazepam, fentanyl, lorazepam, midazolam, morphine, haloperidol |
Ramsay (Yes) |
Nurse- implemented continuous sedation algorithm (n=162) |
Physician-directed continuous sedation (n= 159) |
Hospital dischargec |
1, 3–7 |
Kress et al,8
2000 Single center United States |
128 | Medical (closed)c |
57d | 6ld | 50 | 43.3 | 20d | 22d | COPD or ventilatory failure |
Midazolam, morphine, propofol |
Ramsay (Yesc) |
Daily interruption of sedation until patients were awake (n=68) |
ICU physician— directed sedative interruption (n=60) |
Hospital discharge |
1, 3–8 |
Bucknall et al,12 2008 Single center Australia |
312 | General (closed) |
58.2 | 56.1 | 64 | 58 | 18.6 | 19.5 | Medical | Diazepam, haloperidol, fentanyl, midazolam, morphine, propofol |
SAS (No) |
Nurse- implemented sedation algorithm (n=159) |
Sedation medication type and dose limits for infusion and boluses prescribed by ICU medical staff (n=153) |
Hospital dischargee |
0, 1, 3–6, 8 |
Girard et al,11
2008 Multicenter United States |
335 | Medical (mixed)c |
60d | 64d | 54 | 51 | 26d | 26.5d | Sepsis/ARDS | Benzodiazepines,f haloperidol, opiates,f propofol |
RASS (Yes) |
Nurse- implemented daily interruption of sedation plus a daily spontaneous breathing trial (n=167) |
Sedation per usual care plus a daily spontaneous breathing trial (n=168) |
1 y | 2, 3c, 4, 5g, 6–8 |
Anifantaki et al,10 2009 Single center Greece |
97 | Medical; surgical (closed)c |
52.1 | 56.1 | 71.4 | 72.9 | 17.4 | 18.9 | Trauma | Fentanyl, midazolam, morphine, propofol, remifentanil |
Ramsay (NR) |
Nurse- implemented daily interruption of sedation (n=49) |
ICU medical staff— directed sedation (n=48) |
Hospital discharge |
1, 3–5 |
Weisbrodt et al,9 2011 Multicenter Australia |
50 | Medical surgical trauma (closed)c |
65.1 | 69.1 | 54 | 71 | 23.4 | 21.4 | Respiratory | Fetanyl, midazolam, propofol |
RASS (No) | Daily interruption of fentanyl or midazolam infusions for up to 6 h (n=26) |
Usual management of sedation in Australia (n=24) |
6 moc | 0, 2–6 |
APACHE II = Acute Physiology and Chronic Health Evaluation II; ARDS = acute respiratory disease syndrome; C = control; COPD = chronic obstructive pulmonary disease; 1 = intervention; ICU = intensive care unit; NR = not reported; RASS = Richmond Agitation Sedation Scale; SAS = Riker Sedation-Agitation Scale.
0 = ICU mortality, 1 = hospital mortality 2 = 6- to 12-month mortality, 3 = duration of mechanical ventilation, 4 = ICU length of stay, 5 = hospital length of stay, 6 = incidence of tracheostomy, 7 = incidence of reintubation, 8 = incidence of self-extubation, 9 = incidence of delirium.
Reported via email.
Values are medians not means.
Estimated based on the longest followed mortality measure.
Benzodiazepines as lorazepam and opiates as fentanyl equivalents.
Median hospital length of stay is reported; however, interquartile range is missing in the control group.